A New and Immersive Medical Device for Cognitive Assessment Testing
Altoida’s medical device for cognitive assessment measures brain health in 10 minutes with a battery of immersive augmented reality (AR) activities.
CONNECT WITH USThrough a set of tasks that simulate activities of daily living, Altoida’s software medical device for cognitive assessment puts personalized and actionable brain health measurements in the hands of patients, providers, and researchers.
Cognitive Assessment Device Features
Immersive AR
Altoida’s game-like AR and digital motor activities simulate complex activities of daily living.
10 Minutes
Altoida’s activity battery is designed to be completed in only 10 minutes.
Any Location
Altoida’s cognitive assessment activities can be completed from the comfort of your own home.
Benefits of Early and Continuous Brain Monitoring
When given access to better tools to regularly monitor brain health and diagnose neurological diseases in their beginning stages, individuals can benefit from an earlier understanding and more management options. Early diagnosis can enable early intervention.
Testimonials
The Altoida technology will be applicable in the direct care of patients and for research to help provide the next generation of therapeutic products. A test that will be easy to obtain, simple to perform, readily available, affordable, instantly diagnostic, reliable, and can establish efficaciousness is a remarkable breakthrough in medicine.
Charles Neblett, M.D., Neurosurgeon, Baylor College of Medicine and Consultant/Medical Director at McNair Medical Institute, Houston TX
The Altoida technology offers an ingenious way in which to detect early disease and track progression without prolonged cognitive testing, tissue sampling, or radiologic intervention. The Altoida technology is a welcomed advancement to the field of cognitive health.
Jonathan L. Liss, M.D., Director at Columbus Memory Center and Founder of Columbus Memory Project
Diagnosis of an individual at risk for Alzheimer’s disease has been the biggest challenge in the field of Alzheimer’s disease and the Altoida digital biomarker technology will provide us with an innovative tool to detect the onset of Alzheimer’s disease in a reliable and gamified fashion.
Dr. Namrata Das M.D., MPH, Center for BrainHealth, The University of Texas at Dallas
We are partnering with leaders in therapeutics, research, and care to revolutionize brain health
Together We Can Revolutionize Brain Health
To learn more about how Altoida is building the precision neurology platform to power early Alzheimer’s disease diagnosis and personalized brain analysis, contact us.